Related Experiment Video
Updated: Apr 16, 2026

11:39
The Goeckerman Regimen for the Treatment of Moderate to Severe Psoriasis
Published on: July 11, 2013
39.7K
Juvenile Generalized Pustular Psoriasis: Management in Children-A Case Series.
1Pokhara Academy of Health Sciences Ramghat, Pokhara, Kaski Nepal.
Clinical Case Reports
|April 15, 2026
Summary
Juvenile Generalized Pustular Psoriasis (GPP) is a rare, severe condition. Cyclosporine and Acitretin offer effective management options for pediatric GPP, especially in resource-limited settings.
Area of Science:
- Dermatology
- Pediatrics
- Immunology
Background:
- Juvenile Generalized Pustular Psoriasis (GPP) is an extremely rare, life-threatening inflammatory disease.
- Pediatric GPP lacks established management guidelines.
- Cases presented with erythema, sterile pustules, fever, and malaise, without prior plaque psoriasis history.
Purpose of the Study:
- To report three cases of Juvenile GPP.
- To evaluate treatment strategies for pediatric GPP.
- To highlight the role of Cyclosporine and Acitretin in resource-limited settings.
Main Methods:
- Case series reporting three pediatric patients with GPP.
- Treatment involved Cyclosporine (low dose initially, escalated as needed).
- Acitretin was used as maintenance therapy (25mg alternate days due to capsule availability).
Main Results:
- One patient responded to low-dose Cyclosporine alone.
- Two patients required escalated Cyclosporine doses (≥5mg/kg) due to relapses.
- Acitretin maintenance therapy led to significant improvement and reduced relapse frequency.
Conclusions:
- Cyclosporine and Acitretin are viable therapeutic options for Juvenile GPP.
- These agents are crucial in resource-limited settings where biologics are inaccessible.
- Effective management of pediatric GPP can be achieved with careful titration of these agents.
Related Concept Videos
Acne Infection
72
Acne is a multifactorial skin condition primarily affecting adolescents and young adults, with a global prevalence estimated to exceed 75% in this demographic. The condition is characterized by the formation of comedones (blackheads and whiteheads), papules, pustules, nodules, and, in severe cases, cysts, particularly in areas rich in sebaceous glands such as the face, neck, chest, and back. The pathogenesis involves increased sebum production, follicular hyperkeratinization, colonization by...
72
Nephrotic Syndrome II : Assessment and Medical Management
367
IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document...
367
Pharmacokinetics in Pediatric Patients: Drug Excretion
391
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
391
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
851
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
851
Pharmacokinetics in Pediatric Patients: Drug Metabolism
360
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
360
Tonsillitis II: Management
626
This lesson will focus on the different treatment options for managing tonsillitis, which typically depend on the cause and severity.
626
